Hajime Maeda

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

The World Health Organization histologic classification system reflects the oncologic behavior of thymoma

Meinoshin Okumura, Mitsunori Ohta, Hisashi Tateyama et al. · Cancer · 2002 · 596 citations

Medicine, Oncology, Pathology +17

Hepatocellular carcinoma detected by iodized oil.

Y Yumoto, Kenji Jinno, K Tokuyama et al. · Radiology · 1985 · 291 citations

Medicine, Oncology, Radiology +17

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Paresh Dandona, Pieter Gillard, Peter Senior et al. · Diabetes Care · 2018 · 252 citations

Medicine, Pharmacology, Pharmacotherapy +15

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17